Literature DB >> 31873862

Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy.

Liang En Wee1,2, Mangaikarasi Sundarajoo3, Way-Fang Quah3, Ahmad Farhati3, Jie-Ying Huang3, Ying-Ying Chua3.   

Abstract

While health-related quality of life (HRQoL) is an important component of patient-centred care, few studies have looked at the association between HRQoL and outcomes while on OPAT. From 2014 to 2017, we conducted a prospective cohort study of all patients referred to Singapore General Hospital's (SGH) OPAT service. At baseline, we collected sociodemographic, clinical, and treatment-related factors for OPAT recipients. We also measured baseline HRQoL using the EuroQoL EQ5D-3 L. We evaluated the association between HRQoL and the following outcomes: complications experienced while on OPAT, early termination requiring readmission during planned course of OPAT, all-cause readmission 30 days after completion of OPAT, and return to work while on OPAT. We used chi-squared test for univariate analysis and cox regression for multivariate analysis. From 2014 to 2017, 1213 patients received OPAT at our centre. Of those, 13.2% (160/1213) developed complications. About 10% (132/1213) of patients were readmitted while on OPAT and OPAT was terminated early. Amongst patients who completed OPAT (N = 1081), about 3.6% (39/1081) were readmitted within 30 days after OPAT completion. About half (50.8%, 278/547) returned to work while on OPAT. On multivariate analysis, patients with perfect health-related quality of life (HRQoL) (adjusted relative risk, aRR = 0.62, 95%CI = 0.45-0.85) were less likely to experience complications, had lower risk of OPAT termination (aRR = 0.57, 95%0.38-0.86), and were more likely to return to work while on OPAT (aRR = 1.94, 95%CI = 1.30-2.89). HRQoL at baseline was significantly associated with lower risk of complications and early OPAT termination, as well as greater likelihood of return to work while on OPAT.

Entities:  

Keywords:  Complications; Outpatient antibiotics service; Quality of life; Readmission

Mesh:

Substances:

Year:  2019        PMID: 31873862     DOI: 10.1007/s10096-019-03787-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

Review 1.  Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.

Authors:  Eliane Molina Psaltikidis; Everton Nunes da Silva; Joaquim Murray Bustorff-Silva; Maria Luiza Moretti; Mariângela Ribeiro Resende
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2017-08-04       Impact factor: 2.217

2.  Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.

Authors:  Laura Means; Susan Bleasdale; Monica Sikka; Alan E Gross
Journal:  Pharmacotherapy       Date:  2016-07-29       Impact factor: 4.705

3.  Reduced ability to work both before and after infectious spondylodiscitis in working-age patients.

Authors:  Michala Kehrer; Jesper Hallas; Jesper Bælum; Thøger Gorm Jensen; Court Pedersen; Annmarie Touborg Lassen
Journal:  Infect Dis (Lond)       Date:  2016-09-16

Review 4.  Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.

Authors:  Michael MacKenzie; Nikolas Rae; Dilip Nathwani
Journal:  Int J Antimicrob Agents       Date:  2013-10-14       Impact factor: 5.283

5.  Risk Factors and Effects of Care Management on Hospital Readmissions Among High Users at an Academic Medical Center.

Authors:  Quang H Pham; Sara X Li; Brent C Williams
Journal:  Care Manag J       Date:  2016-09-01

6.  Impaired long-term quality of life in survivors of severe sepsis : Chinese multicenter study over 6 years.

Authors:  K Zhang; X Mao; Q Fang; Y Jin; B Cheng; G Xie; H Li; L Yu; T Zhu; H Wang; X Liu; Y Zhang; Y Jin; N Zhang; T Lou; X M Fang
Journal:  Anaesthesist       Date:  2013-11-30       Impact factor: 1.041

7.  Risk Factors for Complications during Outpatient Parenteral Antimicrobial Therapy for Adult Orthopedic and Neurosurgical Infections.

Authors:  Kimberly K Felder; Lynn M Marshall; Louise E Vaz; Penelope D Barnes
Journal:  South Med J       Date:  2016-01       Impact factor: 0.954

8.  Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation.

Authors:  Linda Bouwman; Corien M Eeltink; Otto Visser; Jeroen J W M Janssen; Jolanda M Maaskant
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

9.  Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.

Authors:  Marie Yan; Marion Elligsen; Andrew E Simor; Nick Daneman
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-02-22       Impact factor: 2.471

10.  Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.

Authors:  Victoria Huang; Jorg J Ruhe; Polina Lerner; Marianna Fedorenko
Journal:  BMC Pharmacol Toxicol       Date:  2018-08-06       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.